Lopes, C. D. H., Kasi, A., Abushahin, L. I., Cardin, D. B., Lenz, H., Dayyani, F., Messersmith, W. A., Ezenwajiaku, N., Oberstein, P. E., Paluri, R. K., Patel, R. A., Pfaff, K. L., Kim, E., Kalyan, A., Smaglo, B. G., Amin, M. A., Hallak, M. N. A., Gbolahan, O. B., Chen, H. X., Spreafico, A. (2026). Final results and preliminary correlative analysis of a phase I study of anetumab ravtansine in combination with checkpoint inhibitors and gemcitabine in mesothelin-positive advanced pancreatic adenocarcinoma (NCI10208).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4205